CINCINNATI (WKRC) - Amid growing concerns over counterfeit weight loss medications, a local clinical trial may offer a safer alternative for those looking to shed pounds. Velocity Clinical ...

Recent clinical studies have revealed groundbreaking developments in treating knee osteoarthritis through metabolic intervention, with Ozempic showing significant improvements in pain reduction ...

Ozempic, a drug initially intended for type 2 diabetes treatment, is gaining popularity for weight loss and reducing cardiovascular risks. However, researchers caution about potential side effects ...

Novo Nordisk, the maker of Ozempic, reported that compounded versions of semaglutide, the main ingredient in Ozempic and Wegovy, have led to at least 100 hospitalizations and 10 deaths.

Slickly designed websites. Unbelievable markdowns. A simple online search for semaglutide, the active ingredient in Ozempic or Wegovy, can lead consumers down a rabbit hole of seemingly reputable ...

But after starting a non-FDA approved GLP-1 agonist—an injectable drug similar to the diabetes drug Ozempic and the weight-loss drug Wegovy—last January, “the appetite absolutely vanished ...

But after starting a non-FDA approved GLP-1 agonist—an injectable drug similar to the diabetes drug Ozempic and the weight-loss drug Wegovy—last January, “the appetite absolutely vanished ...

The national use of weight loss drugs like Ozempic and Wegovy more than doubled as bariatric surgery frequency dropped by about 25 percent from 2022 to 2023, researchers report in an Oct. 25 study ...

Novo Nordisk (NVO) teased some new details about a potential Ozempic successor during a call with investors Tuesday. The Danish pharma giant fielded several questions from interested analysts ...